Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
ContributorsGlatzer, Markus; Leskow, Pawel; Caparrotti, Francesca; Elicin, Olgun; Furrer, Markus; Gambazzi, Franco; Dutly, André; Gelpke, Hans; Guckenberger, Matthias; Heuberger, Jürg; Inderbitzi, Rolf; Cafarotti, Stefano; Karenovics, Wolfram; Kestenholz, Peter; Kocher, Gregor Jan; Kraxner, Peter; Krueger, Thorsten; Martucci, Francesco; Oehler, Christoph; Ozsahin, Mahmut; Papachristofilou, Alexandros; Wagnetz, Dirk; Zaugg, Kathrin; Zwahlen, Daniel; Opitz, Isabelle; Putora, Paul Martin
Published inTranslational lung cancer research, vol. 10, no. 4, p. 1960-1968
Publication date2021
Abstract
Keywords
- Non-small cell lung cancer (NSCLC)
- Decision-making
- Radiotherapy
- Stage III N2 lung cancer
- Surgery
Research groups
Citation (ISO format)
GLATZER, Markus et al. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. In: Translational lung cancer research, 2021, vol. 10, n° 4, p. 1960–1968. doi: 10.21037/tlcr-20-1210
Main files (1)
Article (Published version)
Identifiers
- PID : unige:155766
- DOI : 10.21037/tlcr-20-1210
- PMID : 34012806
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107728/
Journal ISSN2218-6751